LINEAGE INC(NASDAQ:LINE) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to LINE. LINE was compared to 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of LINE have multiple concerns. LINE is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year LINE has reported negative net income.

1.2 Ratios

Looking at the Return On Assets, with a value of -3.68%, LINE is doing worse than 85.71% of the companies in the same industry.

LINE has a worse Return On Equity (-7.85%) than 79.37% of its industry peers.

LINE has a better Return On Invested Capital (3.49%) than 69.05% of its industry peers.

The Average Return On Invested Capital over the past 3 years for LINE is in line with the industry average of 3.11%.

The 3 year average ROIC (1.72%) for LINE is below the current ROIC(3.49%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	-3.68%
ROE	-7.85%
ROIC	3.49%

ROA(3y)-0.58%

ROA(5y)N/A

ROE(3y)-2.17%

ROE(5y)N/A

ROIC(3y)1.72%

ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 8.40%, LINE is doing worse than 84.13% of the companies in the same industry.

LINE has a worse Gross Margin (32.98%) than 90.48% of its industry peers.

		Industry Rank	Sector Rank
OM	8.4%
PM (TTM)	N/A
GM	32.98%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

LINE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

LINE has about the same amout of shares outstanding than it did 1 year ago.

LINE has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.30, we must say that LINE is in the distress zone and has some risk of bankruptcy.

LINE's Altman-Z score of 1.30 is amongst the best of the industry. LINE outperforms 83.33% of its industry peers.

LINE has a Debt/Equity ratio of 0.69. This is a neutral value indicating LINE is somewhat dependend on debt financing.

With a decent Debt to Equity ratio value of 0.69, LINE is doing good in the industry, outperforming 76.19% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.69
Debt/FCF	N/A
Altman-Z	1.3

ROIC/WACC0.5

WACC6.94%

2.3 Liquidity

A Current Ratio of 1.07 indicates that LINE should not have too much problems paying its short term obligations.

The Current ratio of LINE (1.07) is comparable to the rest of the industry.

A Quick Ratio of 0.95 indicates that LINE may have some problems paying its short term obligations.

With a Quick ratio value of 0.95, LINE perfoms like the industry average, outperforming 40.48% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.07
Quick Ratio	0.95

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

LINE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.44%.

The Revenue has grown by 8.38% in the past year. This is quite good.

EPS 1Y (TTM)-23.44%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)8.38%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, LINE will show a very strong growth in Earnings Per Share. The EPS will grow by 53.59% on average per year.

LINE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.51% yearly.

EPS Next Y-701.97%

EPS Next 2Y84.15%

EPS Next 3Y54.4%

EPS Next 5Y53.59%

Revenue Next Year1.81%

Revenue Next 2Y2.83%

Revenue Next 3Y3.77%

Revenue Next 5Y5.51%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

LINE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

The Price/Forward Earnings ratio is 123.41, which means the current valuation is very expensive for LINE.

The rest of the industry has a similar Price/Forward Earnings ratio as LINE.

LINE's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 91.29.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	123.41

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LINE indicates a somewhat cheap valuation: LINE is cheaper than 65.08% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	12.74

4.3 Compensation for Growth

A more expensive valuation may be justified as LINE's earnings are expected to grow with 54.40% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y84.15%

EPS Next 3Y54.4%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

LINE has a Yearly Dividend Yield of 3.03%.

Compared to an average industry Dividend Yield of 18.24, LINE is paying slightly less dividend.

LINE's Dividend Yield is a higher than the S&P500 average which is at 2.27.

		Industry Rank	Sector Rank
Dividend Yield	3.03%

5.2 History

LINE has paid a dividend for less than 5 years, so there is no long track record yet.

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

DPN/A

EPS Next 2Y84.15%

EPS Next 3Y54.4%

More info and screens

Find the best dividend stocks

Show peers with best dividend

LINEAGE INC

NASDAQ:LINE (1/30/2025, 1:39:55 PM)

60.42

+0.75 (+1.26%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)11-06 2024-11-06/bmo

Earnings (Next)N/A N/A

Inst Owners7.67%

Inst Owner Change0.27%

Ins Owners0.03%

Ins Owner Change-1.8%

Market Cap13.80B

Analysts77.27

Price Target84.41 (39.71%)

Short Float %8.9%

Short Ratio4.88

Dividend

		Industry Rank	Sector Rank
Dividend Yield	3.03%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-133.36%

Min EPS beat(2)-165.28%

Max EPS beat(2)-101.44%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-1.66%

Min Revenue beat(2)-1.76%

Max Revenue beat(2)-1.55%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-2.65%

PT rev (3m)-11.02%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-16%

EPS NY rev (1m)0%

EPS NY rev (3m)N/A

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-0.72%

Revenue NY rev (1m)-0.22%

Revenue NY rev (3m)-0.35%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	123.41
P/S	1.48
P/FCF	N/A
P/OCF	N/A
P/B	1.53
P/tB	3.16
EV/EBITDA	12.74

EPS(TTM)-3.33

EYN/A

EPS(NY)0.49

Fwd EY0.81%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS40.9

BVpS39.52

TBVpS19.09

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.68%
ROE	-7.85%
ROCE	4.42%
ROIC	3.49%
ROICexc	3.57%
ROICexgc	4.89%
OM	8.4%
PM (TTM)	N/A
GM	32.98%
FCFM	N/A

ROA(3y)-0.58%

ROA(5y)N/A

ROE(3y)-2.17%

ROE(5y)N/A

ROIC(3y)1.72%

ROIC(5y)N/A

ROICexc(3y)1.74%

ROICexc(5y)N/A

ROICexgc(3y)2.38%

ROICexgc(5y)N/A

ROCE(3y)2.18%

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-ScoreN/A

Asset Turnover0.49

Health

		Industry Rank	Sector Rank
Debt/Equity	0.69
Debt/FCF	N/A
Debt/EBITDA	4.05
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.07
Quick Ratio	0.95
Altman-Z	1.3

F-ScoreN/A

WACC6.94%

ROIC/WACC0.5

Cap/Depr(3y)111.66%

Cap/Depr(5y)N/A

Cap/Sales(3y)16.48%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-23.44%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next Y-701.97%

EPS Next 2Y84.15%

EPS Next 3Y54.4%

EPS Next 5Y53.59%

Revenue 1Y (TTM)8.38%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next Year1.81%

Revenue Next 2Y2.83%

Revenue Next 3Y3.77%

Revenue Next 5Y5.51%

EBIT growth 1Y29.34%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year170.09%

EBIT Next 3Y46.08%

EBIT Next 5YN/A

FCF growth 1Y109.39%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y58.73%

OCF growth 3YN/A

OCF growth 5YN/A

LINEAGE INC (LINE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens